Topas Therapeutics

Developer of nanoparticle-based therapeutics for immunology disorders

placeHamburg, Hamburg, Germany calendar_todayFounded 2016 groups14 employees language topas-therapeutics.com

Registered entities

Social engagement

Social engagement: 1.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Epidarex Capital, Vesalius Biocapital III, BioMedPartners.

Investor typeCountShare
Venture capital556%
Private equity111%
Other / undisclosed333%

Recent activity

29 Jun 2026
Event
Sixth Newcastle Therapeutic Tolerance Workshop
15 Jun 2026
Event
Sixth Newcastle Therapeutic Tolerance Workshop
13 Apr 2026
Event
Nanotech in Life Science conference
Coming soon